✦ LIBER ✦

Activated protein C-resistance due to factor V leiden mutation among patients with inflammatory bowel disease: A case-control study

✍ Scribed by Ardizzone, S.; Bollani, S.; Molteni, P.; Russo, U.; Rossi, E.; Bianchi Porro, G.

Book ID: 123554863
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 174 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)83755-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What is the impact of resistance to acti

What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?

✍ Emma Attvall; Attila Frigyesi; Berit Sternby 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 117 KB

Resistance to activated protein C due to

Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers

✍ Y. Gaber; H-J. Siemens; W. Schmeller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Background: Activated protein c (apc) resistance is the most frequently diagnosed heritable thrombophilic defect predisposing to thrombosis. ## Objectives: To determine the prevalence of apc resistance due to factor v leiden mutation in patients with leg ulcers. ## Methods: Within a 2-year-p

Increased frequency of a mutation in coa

Increased frequency of a mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease

✍ M. Chen; H. Seydewitz; B. Winckelmann; M. Nauck; H. Wieland; L. Witt; W. März 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Population study of the G1691A mutation

Population study of the G1691A mutation (R506% FV Leiden) in the human factor V gene that is associated with resistance to activated protein C

✍ A. Braun,B. Müller,A. A. Rosche 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 25 KB

Homocysteinemia(HCY), factor V leiden (F

Homocysteinemia(HCY), factor V leiden (FVI691A) and protjrombin gene mutation (PT20210A), activated protein C resistance (APCR), antithrombin III deficiency (ATIIID), protein C and protein S deficiency (PCD, PSD), lupus anticoagulant(LAC) and anticardiolipin antibodies (ACA) in patients with inflammatory bowel disease (IBD)

✍ Abbati, Gianluca; Ventura, Paolo; Marietta, Marco; Panini, Rossana; Salvioli, Gi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Phenprocoumon-Induced Hepatitis Delaying

Phenprocoumon-Induced Hepatitis Delaying Precise Diagnosis in a Thrombophilic Patient With Activated Protein C Resistance Due to Factor V R506Q Mutation

✍ Walter A Wuillemin MD; PhD; Reinhard Zenhäusern MD; Marie-Claire Bernhard MD; Be 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 58 KB